| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/09/2002 | EP1169052A2 Angiogenic growth factors for treatment of peripheral neuropathy |
| 01/09/2002 | EP1169051A2 Therapeutic uses of bpi protein products in bpi-deficient humans |
| 01/09/2002 | EP1169050A1 Ocular treatment using cyclosporin-a derivatives |
| 01/09/2002 | EP1169049A2 Treatment of myeloma bone disease with proteasomal and nf-kappa-b activity inhibitors |
| 01/09/2002 | EP1169048A2 Hyaluronic acid mimics and methods related thereto |
| 01/09/2002 | EP1169045A2 Immunomodulating polymers |
| 01/09/2002 | EP1168997A1 Vacuum assisted closure system with provision for introduction of agent |
| 01/09/2002 | EP1168934A1 Hydrogel-forming system with hydrophobic and hydrophilic components |
| 01/09/2002 | EP1168923A1 Dna vaccination for treatment of autoimmune disease |
| 01/09/2002 | EP1168919A2 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion |
| 01/09/2002 | EP1168917A2 Human lung cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP1073463A4 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation |
| 01/09/2002 | EP0984699A4 Method of inhibiting immune system destruction of transplanted viable cells |
| 01/09/2002 | EP0866806A4 Method of mobilizing hematopoietic stem cells |
| 01/09/2002 | EP0789764B1 A novel family of protease inhibitors, and other biologic active substances |
| 01/09/2002 | EP0785795B1 A pharmaceutical formulation comprising a growth hormone and valine |
| 01/09/2002 | EP0728146B1 Conotoxin peptides |
| 01/09/2002 | EP0702561B1 Treatment of neuromuscular disorders and conditions with botulinum serotyp e |
| 01/09/2002 | CN1330718A Therapeutically active proteins in plants |
| 01/09/2002 | CN1330714A Virulence genes and proteins and their use |
| 01/09/2002 | CN1330713A Zinc finger binding domains for GNN |
| 01/09/2002 | CN1330665A Multiple domain glycoprotein hormones and methods of using |
| 01/09/2002 | CN1330664A Platelet-derived growth factor C, DNA coding therefor and uses thereof |
| 01/09/2002 | CN1330663A Hypoxia-inducible factor I-alpha HIF-I-alpha variants and methods for identifying HIF-I-alpha modulators |
| 01/09/2002 | CN1330661A Procollagen C-proteinase inhibitors |
| 01/09/2002 | CN1330660A Cycle tetrapeptide compound and their use |
| 01/09/2002 | CN1330658A Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 01/09/2002 | CN1330637A Compounds useful in treatment of infammatory diseases |
| 01/09/2002 | CN1330557A In situ injection of antigen-presenting cells with generatically enhanced cytokine expression cell factor |
| 01/09/2002 | CN1330556A Combination therepy of angiotensin-converting enzyme inhibor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease |
| 01/09/2002 | CN1330551A Pharmaceutical formulation of Didemnin compound |
| 01/09/2002 | CN1330550A Use of substances with oxytocin activity in order to create cell regeneration |
| 01/09/2002 | CN1330539A Compositions and methods for treatment of anorectal disorders |
| 01/09/2002 | CN1330517A Food-induced antisecretory proteins in egg yolk |
| 01/09/2002 | CN1330146A Polypeptide-human dynein receptor-similar kinase 43 and polynucleotide for coding it |
| 01/09/2002 | CN1330077A Endothelin antegon |
| 01/09/2002 | CN1330076A Endothelin antagon |
| 01/09/2002 | CN1330075A Endothelin antagon |
| 01/09/2002 | CN1330073A Peptide nucleic acid derivatives, intermediate for preparing them and medicinal composition containing them |
| 01/09/2002 | CN1329923A Concentrated granular medicine for treating baby diarrhea and its preparing process |
| 01/09/2002 | CN1329922A Join of C peptide and insulin for treating diabetes complication and C peptide-specific antibody |
| 01/09/2002 | CN1329921A Orally applied medicine containing Nostoc which expressing human tumor necrosin factor alpha |
| 01/09/2002 | CN1329920A Process for preparing medicine composition containing glutacthion or its salt |
| 01/09/2002 | CN1077439C Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 01/09/2002 | CN1077438C Recombinant coccidiosis vaccines |
| 01/08/2002 | US6337394 N-acyl-heterocycle-carboxyamides that are n-substituted with amidino-substituted rings; competitive inhibitors of thrombin; anticoagulants |
| 01/08/2002 | US6337389 Method and process for the production of collagen preparations from invertebrate marine animals and compositions thereof |
| 01/08/2002 | US6337387 A polypeptide encoding a human notch ligand molecule; for suppressing differentiation of undifferentiated cells and drug development |
| 01/08/2002 | US6337385 Cyclic peptides |
| 01/08/2002 | US6337343 Amino acid derivatives |
| 01/08/2002 | US6337327 Drugs for enzyme inhibiting such as angiotensin converting enzyme |
| 01/08/2002 | US6337325 Combined preparation for the therapy of immune diseases |
| 01/08/2002 | US6337321 Treaatment of cardiovascular disorders in mammals |
| 01/08/2002 | US6337320 Reparatives for ultraviolet radiation skin damage |
| 01/08/2002 | US6337319 μ-Selective opioid peptides |
| 01/08/2002 | US6337318 Drugs for peptide agonist |
| 01/08/2002 | US6337317 Amino acid sequence peptides as microbiocides |
| 01/08/2002 | US6337316 Pharmaceutical compositions thereof, and methods of using same |
| 01/08/2002 | US6337315 Anti-inflammatory compositions comprising peptide derivatives of α-MSH/algal extracts |
| 01/08/2002 | US6337314 Mammalian-derived peptides for the treatment of microbial infections |
| 01/08/2002 | US6337209 Molecular constructs containing a carcinoembryonic antigen regulatory sequence |
| 01/08/2002 | US6337206 Nucleic acid encoding mouse galanin receptor (GALR2) |
| 01/08/2002 | US6337200 A polynucleotide encoding a reverse transcriptase having catalytic activity; therapy of human disease related to cellular proliferation, senescence, and cancer |
| 01/08/2002 | US6337192 A synthetic nucleic acid encoding a tumor suppressor protein; therapy for breast cancer, kidney cancers, skin disorders, vascular malformations and intestinal polyps |
| 01/08/2002 | US6337187 An isolated nucleic acid molecule; diagnosis and therapy for obesity, hypertriglyceridemia, and atherosclerosis |
| 01/08/2002 | US6337094 Bioavailability |
| 01/08/2002 | US6337093 Immunomodulatory and antimicrobial materials, their preparation and use |
| 01/08/2002 | US6337075 Methods for treating diabetes |
| 01/08/2002 | US6337074 Antiviral agent capable of disrupting the association of two viral proteins required for dna replication in herpesviruses |
| 01/08/2002 | US6337072 For diagnosis, therapy and research |
| 01/08/2002 | US6337070 Polypeptides for use in generating anti-human influenza virus antibodies |
| 01/08/2002 | US6337069 Method of treating rhinitis or sinusitis by intranasally administering a peptidase |
| 01/08/2002 | CA2163636C Process for the sterilization of biological compositions and the product produced thereby |
| 01/08/2002 | CA2159915C Systemic effects of nitric oxide inhalation |
| 01/08/2002 | CA2148138C Biological factors and neural stem cells |
| 01/08/2002 | CA2116560C Morphogenic protein screening method |
| 01/08/2002 | CA2092905C Treatment of autoimmune diseases by oral administration of autoantigens |
| 01/08/2002 | CA2057493C A process for the preparation of a pasteurized and iron-free human transferrin |
| 01/08/2002 | CA2042001C Peptide amides, processes for the preparation thereof and agents containing these as fibrin/thrombin clotting inhibitors |
| 01/08/2002 | CA2021594C Antibody to human interleukin-6 receptor |
| 01/08/2002 | CA2019559C Bispecific and oligospecific mono- and oligovalent receptors, the preparation and use thereof |
| 01/03/2002 | WO2002000913A2 MODULATION OF β-AMYLOID LEVELS BY β-SECRETASE BACE2 |
| 01/03/2002 | WO2002000906A2 Replication deficient adenoviral tnf vector |
| 01/03/2002 | WO2002000893A1 Materials and methods relating to the increase in protein activity |
| 01/03/2002 | WO2002000891A2 Human napsin-like aspartyl protease |
| 01/03/2002 | WO2002000887A1 Novel therapeutic molecular variants and uses thereof |
| 01/03/2002 | WO2002000882A2 Transport peptides dirived from erns protein, cytotoxic rnase of ribosome-inactivating protein or a rsv g-protein and analogues thereof |
| 01/03/2002 | WO2002000879A2 Methods for producing modified glycoproteins |
| 01/03/2002 | WO2002000878A2 Human msp1 mitochondrial dynamin, its msp1-x isoforms, and their therapeutic use |
| 01/03/2002 | WO2002000877A2 Antisense oligonucleotides to inhibit angiogenesis and/or metastasis |
| 01/03/2002 | WO2002000876A1 Truncated egf receptor |
| 01/03/2002 | WO2002000872A2 Compositions and methods for treating or detecting degenerative diseases of the motor neurons |
| 01/03/2002 | WO2002000862A2 32447, a novel human acyltransferase and uses thereof |
| 01/03/2002 | WO2002000860A2 Novel proteases |
| 01/03/2002 | WO2002000856A2 Protein glycosylation modification in pichia pastoris |
| 01/03/2002 | WO2002000854A2 Regulation of human phosphodiesterase-like enzyme |
| 01/03/2002 | WO2002000853A2 Regulation of human caspase-1-like protease |
| 01/03/2002 | WO2002000840A2 Human lyases |
| 01/03/2002 | WO2002000839A2 Statement as to federally sponsored research |
| 01/03/2002 | WO2002000833A2 A novel polypeptide gamma carboxyl glutamic acid protein 113.31 with abundant proline and the polynucleotide coding this novel peptide |